Repeat Participation among Normal Healthy Research Volunteers: Professional guinea pigs in clinical trials?

Perspectives in Biology and Medicine

Volumn 46, Issue 4, 2003, Pages 508-520

  Tishler, Carl L ^a   Bartholomae, Suzanne ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAUSE OF DEATH; CENTRALIZATION; CLINICAL RESEARCH; FEE; HUMAN; HUMAN EXPERIMENT; MEDICAL ETHICS; MEDICAL RESEARCH; METHODOLOGY; NORMAL HUMAN; PATIENT RIGHT; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SOLDIER; VOLUNTEER;

CAVIA;

EID: 0242333172     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: 10.1353/pbm.2003.0094     Document Type: Review

References (47)

1. Activities Commission. 1987. Advice to health ministers on healthy volunteer studies. London: Department of Health and Social Security.
2. Anderson, J.A., and C. Weijer. 2001.The research subject as entrepreneur. Am. J. Bioethics 1:67-69.
3. Apseloff, G., J. K. Swayne, and N. Gerber. 1996. Medical histories may be unreliable in screening volunteers for clinical trials. Clin. Pharmacol. Ther. 60:353-56.
4. Apseloff, G., et al. 1994. The importance of measuring cotinine levels to identify smokers in clinical trials. Clin. Pharmacol. Ther. 56:460-62.
5. Beaufils, F. 2001.The French law on the protection of people who participate in biomedical research needs to be revised. Arch. Pediatr. 8:634-38.
6. Bielski, R. J., and R. B. Lydiard. 1997. Therapeutic trial participants: Where do we find them and what does it cost? Psychopharmacol. Bull. 33:75-78.
7. Bigorra, J., and J. E. Banos. 1990. Weight of financial reward in the decision by medical students and experienced healthy volunteers to participate in clinical trials. Eur. J. Clin. Pharmacol. 38:443-46.
8. Bor, J., and T. Pelton. 2001. Hopkins faults safety lapses. Baltimore Sun (17 July). 〈http:// www.sunspot.net/news/health/bal-te.md. hopkins17jul17.story?coll=bal%2D home%2Dheadlines〉.
9. Butler, R. W., M. A. Jenkins, and D. L. Braff. 1993. The abnormality of normal comparison groups: The identification of psychosis proneness and substance abuse in putatively normal research subjects. Am. J. Psychiatry 150:1386-91.
10. Cassileth, B. R., et al. 1982. Attitudes toward clinical trials among patients and the public. JAMA 248:968-70.
11. Dawirs, R. R, and G. Teuchert-Noodt. 2001. A novel pharmacological concept in an animal model of psychosis. Acta Psychiatr. Scand. Suppl. 408:10-17.
12. Food and Drug Administration (FDA). 1997. International Conference on Harmonisation: Guidance on general considerations for clinical trials. No. 97D-0188. Fed. Register 62 (17 Dec.).
13. Giffels, J. J. 1996. Clinical trials: What you should know before volunteering to be a research subject. New York: Demos Medical Publishing.
14. Hassar, M., et al. 1977. Free-living volunteer's motivations and attitudes toward pharmacologic studies in man. Clin. Pharmacol. Ther. 21:515-19.
15. Helms, R. 2002. Guinea pig zero: Statement of purpose. 〈http://www.guineapigzero.com.〉 Accessed 29 Jan. 2002.
16. Hermann, R., et al. 1997. Adverse events and discomfort in studies on healthy subjects: The volunteer's perspective. Eur. J. Clin. Pharmacol. 53:207-14.
17. Hogshire, J. 1992. Sell yourself to science: The complete guide to selling your organs, body fluids, bodily functions and being a human guinea pig. Port Townsend, WA: Loompanics Press.
18. Jaillon, P. 1990. Healthy volunteers data bank: Where and how? Fundam. Clin. Pharmacol. 4(suppl. 2):177S-181S.
19. Joubert, P., L. Rivera-Calimlim, and L. Lasagna. 1975. Commentary. The normal volunteer in clinical investigation: How rigid should selection criteria be? Clin. Pharmacol. Ther. 17:253-57.
20. Joyce, P. R., R. T. Mulder, and C. R. Cloninger. 1994.Temperament predicts clomipramine and desipramine response in major depression. J. Affect. Disord. 30:35-46.
21. Lasagna, L., and J. M. von Felsinger. 1963. The volunteer subject in research. In Clinical investigation in medicine: Legal, ethical, and moral aspects; an anthology and bibliography, ed. I. Ladimer and R. W. Newman, 440-45. Boston: Boston Univ. Law-Medicine Research Institute.
22. Lemonick, M. D., and A. Goldstein. 2002. Human guinea pigs. Time (22 April).
23. Macklin, R. 1981. On paying money to research subjects. Irb: Rev. Human Subjects Res. 3: 1-6.
24. Mallin, J. P., Director of NIH Clinical Research Volunteer Program. 2001. Personal communication, June 20.
25. Meyer, F. 2001. Psycho-and immunopharmacological factors relevant to selection of volunteers in clinical studies. Int. J. Clin. Pharmacol. Therapeutics 39:300-310.
26. Nakano, S., N. Ogawa, and Y. Kawazu. 1980. Influence of neuroticism level on diazepam absorption. Clin. Pharmacol. Ther. 25:239-45.
27. National Bioethics Advisory Commission (NBAC). 2001. Ethical and policy issues in research involving human participants. Bethesda, MD: NBAC.
28. National Institutes of Health (NIH). 2002. The clinical research volunteer program for healthy volunteers at the National Institutes of Health. 〈http://www.cc.nih.gov/ccc/ prpl/healthyvols.html〉.
29. Novak, E., C. E. Seckman, and R. D. Stewart. 1977. Motivations for volunteering as research subjects. J. Clin. Pharmacol. 17:365-71.
30. Orme, M., et al. 1989. Healthy volunteer studies in Great Britain: The results of a survey into 12 months activity in this field. Br. J. Clin. Pharmacol. 27:125-33.
31. Pieters, M. S., et al. 1992. Self-selection for personality variables among healthy volunteers. Br. J. Clin. Pharmacol. 33:101-6.
32. Pollin, W., and S. Perlin. 1958. Psychiatric evaluation of "normal control" volunteers. Am. J. Psychiatry 115:129-33.
33. Risch, S. C., et al. 1990. Ensuring the normalcy of "normal" volunteers. Am. J. Psychiatry 147:682-83.
34. Robinson, D., et al. 1996. Subject selection biases in clinical trials: Data from a multicenter schizophrenia treatment study. J. Clin. Psychopharmacol. 16:170-76.
35. Royal College of Physicians of London. 1986. Research on healthy volunteers: A report of the Royal College of Physicians. J. R. Coll. Physicians Lond. 20:243-57.
36. Rush, M. C., J. S. Phillips, and P. E. Panek. 1978. Subject recruitment bias: The paid volunteer subject. Percept. Mot. Skills 47:443-49.
37. Schechter, D., et al. 1998. Selection of "normal" control subjects for psychiatric research: Update on a model for centralized recruitment. Psychiatry Res. 79:175-85.
38. Schrogie, J. J., et al. 1977. Evaluation of the prison inmate as a subject in drug assessment. Clin. Pharmacol. Ther. 21:1-8.
39. Singh, S. D., and A. J. Williams. 1999.The prevalence and incidence of medical conditions in healthy pharmaceutical company employees who volunteer to participate in medical research. Br. J. Clin. Pharmacol. 48:25-31.
40. Smith, E. E. 1963. Obtaining subjects for research. In Clinical investigation in medicine: Legal, ethical, and moral aspects: An anthology and bibliography, ed. I. Ladimer and R. W. Newman, 26-30. Boston: Boston Univ. Law Medicine Research Institute.
41. Tishler, C. L., and S. Bartholomae. 2002. The recruitment of normal healthy volunteers: A review of the literature on the use of financial incentives. J. Clin. Pharmacol. 42:365-75.
42. Tishler, C. L., and L. B. Gordon. 1999. Ethical parameters of challenge studies inducing psychosis with ketamine. Ethics Behav. 9:211-17.
43. U.S. National Commission for the Protection of Human Subjects of Biomedical Research. 1979. The Belmont Report: Ethical principles and guidelines for protection of human subjects of research. DHEW publication nos. (OS) 78-0012 to (OS) 78-0014. Bethesda, MD: U.S. National Commission for the Protection of Human Subjects of Biomedical Research.
44. Vere, D.W. 1991. Payments to healthy volunteers: Ethical problems. Br. J. Clin. Pharmacol. 32:141-42.
45. Vrhovac, R., I. Francetic, and K. Rotim. 1990. Drug trials on healthy volunteers in Yugoslavia. Int. J. Clin. Pharmacol. Ther. 28:375-79.
46. Weissman, L., et al. 1972. Personality factors in prison volunteers related to response in clinical drug trials. J. Clin. Pharmacol. 12:5-10.
47. Zink, S. 2001. Maybe we should pay them more. Am. J. Bioethics 1:88-89.